Transdermal Drug Delivery Systems Market Size, Share, Trends, Growth 2023-2030

Transdermal Drug Delivery Systems Market Snapshot

“The Transdermal Drug Delivery Systems Market to grow from USD 6.89 billion in 2023 to USD 14.72 Billion by 2030, at a CAGR of 4.2%.”

Transdermal drug delivery systems aim to improve the effectiveness of oral medications, which currently account for 74% of prescriptions. These systems, which are applied to the skin, deliver active medications directly into the bloodstream, offering benefits such as reduced hepatic metabolism, increased therapeutic efficacy, and stable drug plasma levels.

The adhesive is crucial for the system's safety, effectiveness, and quality, as it allows the medication to enter the bloodstream.

This analysis explores the advantages of topical drug delivery over standard oral and invasive methods. It discusses the effects of partitioning, solubility, chemical enhancers, and stratum corneum hydration on these methods.

The aim is to provide a platform for research and development of transdermal drug delivery dosage forms, focusing on recent developments in transdermal drug delivery systems.

Transdermal drug delivery offers advantages such as better efficacy-to-tolerability ratio, controlled release, and prevention of pre-systemic metabolism. It is particularly beneficial for patients with diabetes, as patches are particularly effective in delivering insulin.

The market for transdermal drug delivery systems is influenced by healthcare expenditures, product installations, technology impact, and regulatory changes, providing a comprehensive analysis of the market's growth, installed base, life line curves, and the impact of technology on healthcare.

>>>Download Sample Report Now:https://marketreportservice.com/request-sample/transdermal-drug-delivery-systems-market-54712 

Recent advances in transdermal drug delivery systems

Transdermal drug delivery system (TDDS) is a non-invasive alternative to traditional needle injections, offering low rejection rates, ease of administration, and patient convenience. It's particularly appealing in the pharmaceutical industry and the skin care sector, including cosmetics, as it avoids nonspecific drug distribution and local drug concentration buildup due to its primarily local administration approach.

Transdermal delivery of drugs is hindered by skin's physicochemical characteristics, prompting extensive research into solutions. This review outlines various TDDS approaches, their advantages and disadvantages, characterization techniques, and potential.

The high efficiency of these methods has been demonstrated through advancements in research, and they are expected to be utilized in various fields.

Segment Analysis

Transdermal patches and semisolids are product-based market segments for transdermal medication delivery systems. In 2022, transdermal patches dominated the market due to new technologies like mechanical arrays or microneedles.

However, semisolids are expected to grow at the fastest rate due to increasing production capacity using inorganic tactics.

The market for transdermal drug delivery systems is divided into five categories: electric current, iontophoresis, electroporation, ultrasound, and microporation.

The iontophoresis category, which dominated in 2022, is expected to grow rapidly from 2022-2030 due to technological advancements.

This technology enhances skin penetration and increases release rates for various transdermal drug delivery systems, despite poor absorption/permeation profiles.

Microporation is predicted to experience the fastest growth in the forecast period due to the increasing number of new products from industry players and the high market growth of mechanical array or microneedle transdermal drug delivery systems nearing the end of clinical trials.

Growth Drivers

Cardiovascular diseases (CVDs) are common causes of death worldwide, accounting for over 17.9 million deaths annually. Traditional medications like tablets and capsules are ineffective in managing these conditions. Innovative medication delivery strategies, such as transdermal drug delivery systems (TDDS), offer targeted administration to the affected areas and extended drug bioavailability. TDDS offers several benefits over oral medication administration in treating CVDs.

Transdermal patches, containing medication particles, are applied to the skin for cell engraftment. Cardiac patches are ideal for treating ischemic heart ailments, such as angina. They reduce oxygen demand by relaxing blood vessels and reducing heart strain. Recent developments in vascularized cardiac patches show promising results.

• The prevalence of chronic diseases is on the rise.
• The use of transdermal patches is on the rise.
• Growing demand for non-invasive drug delivery system

Restraints

After the recommended use duration, topical patches, transdermal drug delivery systems (TDDS), and transmucosal drug delivery systems (TMDS) may retain 10-95% of the original medicine as a residual drug, posing a risk to patients' safety and their loved ones.

Unavoidable events from patients using TDDS can intensify or prolong the drug's pharmacological impact, and some children have died after accidentally coming into contact with abandoned TDDS.

• The development of drug delivery systems is a costly endeavor.
• Recalls of transdermal drug delivery systems and drug failure

Opportunities

The manufacturers are implementing strategic activities to achieve their goals.

Trends

The adoption of third-generation delivery systems is on the rise.

The demand for geriatric medications has surged due to population growth, leading to a rise in chronic illnesses like diabetes, arthritis, and heart disease. This has prompted increased R&D efforts to enhance medication efficacy and increased patient awareness about medication usage.

This has positively impacted the global CAGR of the transdermal drug delivery systems market, as these factors have led to a significant increase in the number of individuals with these chronic illnesses, which are the primary cause of death and disability.

Competitive Landscape of the Transdermal Drug Delivery Systems Market Analysis

• Hisamitsu Pharmaceutical (Japan)
• Mylan (US)
• UCB (Belgium)
• Novartis (Switzerland)
• GlaxoSmithKline (UK)
• Boehringer Ingelheim (Germany)
• Johnson & Johnson (US)
• Endo International (Ireland)
• and Purdue Pharma (US).

New Developments in Transdermal Drug Delivery Systems Market

In October 2023, Novartis completed a 100% spin-off of Sandoz, its Generics and Biosimilars business, to create an independent company.

June 30, 2022 — Novartis acquires Kedalion Therapeutics and its innovative ocular delivery platform that could transform patient experience.

Novartis announced that it has acquired Kedalion Therapeutics and its AcuStream™ technology, an innovative device that may have the potential to facilitate precise dosing and accurate delivery of certain topical ophthalmic medications to the eye. The acquisition enhances the Novartis ophthalmics portfolio, advancing efforts to investigate transformative ophthalmic methods to address unmet patient needs in front-of-eye conditions.

In December 2022, Luye Pharma Group held an offline product launch conference in Shanghai, along with an online event, to announce the launch of Ruoxinlin (Toludesvenlafaxine hydrochloride extended-release tablets) in China. Ruoxinlin is China’s first class-1 innovative chemical drug independently developed for the treatment of major depressive disorder (MDD) through a local administration and protected by intellectual property rights. The drug provides a powerful new option for patients, bringing the treatment of MDD to a new level.

Feb 2020, GlaxoSmithKline announced that the FDA has approved Voltaren Arthritis Pain as an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults. With the FDA’s approval, Voltaren Arthritis Pain becomes the first and only prescription strength, nonsteroidal anti-inflammatory (NSAID) topical gel for arthritis pain available OTC in the United States.

Dec 2019, Hisamitsu Pharmaceutical Co., Inc. launched HARUROPI TAPE, transdermal, Parkinson’s disease treatment patch in Japan from December 17, 2019 following National Health Insurance (NHI) drug price listing on November 19, 2019.

Jul 2019, Luye Pharma Group has announced that the German Federal Institute for Drugs and Medical Devices has approved the marketing authorization of the company’s Rivastigmine once-a-day transdermal patch in a dosage of 13.3mg/24h. The high dosage strength comes in addition to two other dosage strengths already on the market, 4.6mg/24h and 9.5mg/24h, helping doctors provide more suitable dosages to patients in accordance with their needs.

Regional Analysis of Global Transdermal Drug Delivery Systems Industry

The North America transdermal medication delivery system market is projected to grow at a healthy pace through 2030, accounting for over 45% of the market's revenue in 2022, despite the increasing prevalence of unhealthy lifestyles and disease rates.

North America is expected to experience significant growth due to the repositioning of outdated medications and improvements in current drug formulations in the US and Canada.

The Asia Pacific region is expected to become the world market region with the highest income due to the increasing number of chronic illness patients in developed and developing nations, including China and India.

The global market for transdermal drug delivery systems is expected to grow moderately in Latin America, the Middle East, and Africa due to the presence of less established market participants in these regions.

Segments Covered in the Transdermal Drug Delivery Systems Market Report

Transdermal Drug Delivery Systems Market Segment by Product

• Transdermal Patches
• Semisolids

Transdermal Drug Delivery Systems Market Segment by Technology

• Electric Current
• Iontophoresis
• Electroporation
• Ultrasound
• Microporation

Transdermal Drug Delivery Systems Market by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Rest of the World
• Middle East
• Africa
• Latin America

Frequently Asked Questions

What are some applications of Transdermal Drug Delivery Systems?

Transdermal medication administration involves applying it topically to the skin, which is then absorbed into the bloodstream, offering a simple and effective method for administering medications.

What is the expected growth rate of the Transdermal Drug Delivery Systems market over the next 7 years?

The Transdermal Drug Delivery Systems Market to grow from USD 6.89 billion in 2023 to USD 14.72 Billion by 2030, at a CAGR of 4.2%.

Who are the major players in the Transdermal Drug Delivery Systems market and what is their market share?

Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US), are prominent players operating and dominating in the market.

Who are the top 3 Transdermal Drug Delivery Systems Market Key Vendors?

Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), are key players in the Transdermal Drug Delivery Systems market.

Which geographical areas dominate the worldwide market for Transdermal Drug Delivery Systems?

North America region are emerging as the top regional markets for Transdermal Drug Delivery Systems solutions.

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope and definitions

1.3    Base estimates and working

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Transdermal drug delivery systems industry 360⁰ synopsis, 2018 - 2030

2.1.1    Business trends

2.1.2    Type trends

2.1.3    Application trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Transdermal Drug Delivery Systems Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2023– 2030

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Increasing prevalence of chronic diseases

3.3.1.2   Increasing adoption of transdermal patches

3.3.1.3   Growing demand for non-invasive drug delivery system

3.3.2    Industry pitfalls & challenges

3.3.2.1   Limited number of approved medications

3.3.2.2   High cost involved in development of drug delivery systems

3.4    Growth potential analysis

3.4.1    By type

3.4.2    By application

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.7    Advancement in transdermal drug delivery systems

3.8    Transdermal forms containing the specified active substance, %

3.9    Pricing analysis, by type, 2022

3.10    Porter’s analysis

3.11    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Company positioning matrix

4.4    Competitive analysis of major market players

4.5    Strategic outlook matrix

4.6    Strategy dashboard, 2021

Chapter 5   Transdermal Drug Delivery Systems Market, By Type

5.1    Key type trends

5.2    Transdermal patches

5.2.1    Market estimates and forecast, 2023 - 2030 (USD Million)

5.2.2    Drug-in-adhesive patches

5.2.2.1   Market estimates and forecast, 2023 - 2030 (USD Million)

5.2.3    Matrix patches

5.2.3.1   Market estimates and forecast, 2023 - 2030 (USD Million)

5.2.4    Reservoir membrane patches

5.2.4.1   Market estimates and forecast, 2023- 2030 (USD Million)

5.2.5    Microneedle patches

5.2.5.1   Market estimates and forecast, 2023 - 2030 (USD Million)

5.3    Transdermal semisolids

5.3.1    Market estimates and forecast, 2023 - 2030 (USD Million)

5.3.2    Gels

5.3.2.1   Market estimates and forecast, 2023 - 2030 (USD Million)

5.3.3    Ointments

5.3.3.1   Market estimates and forecast, 2023 - 2030 (USD Million)

5.3.4    Sprays

5.3.4.1   Market estimates and forecast, 2023 - 2030 (USD Million)

Chapter 6   Transdermal Drug Delivery Systems Market, By Application

6.1    Key application trends

6.2    Pain management

6.2.1    Market estimates and forecast, 2023 - 2030 (USD Million)

6.3    Hormonal application

6.3.1    Market estimates and forecast, 2023 - 2030 (USD Million)

6.4    Central nervous system disorders

6.4.1    Market estimates and forecast, 2023 - 2030 (USD Million)

6.5    Cardiovascular diseases

6.5.1    Market estimates and forecast, 2023 - 2030 (USD Million)

6.6    Others

6.6.1    Market estimates and forecast, 2023 - 2030 (USD Million)

Chapter 7   Transdermal Drug Delivery Systems Market, By End-use

7.1    Key end-use trends

7.2    Hospitals

7.2.1    Market estimates and forecast, 2023 - 2030 (USD Million)

7.3    Clinics

7.3.1    Market estimates and forecast, 2023 - 2030 (USD Million)

7.4    Homecare settings

7.4.1    Market estimates and forecast, 2023 - 2030 (USD Million)

7.5    Others

7.5.1    Market estimates and forecast, 2023 - 2030 (USD Million)

Chapter 8   Transdermal Drug Delivery Systems Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Italy

8.3.5    Spain

8.3.6    Poland

8.3.7    Switzerland

8.3.8    The Netherlands

8.4    Asia Pacific

8.4.1    Japan

8.4.2    China

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Indonesia

8.4.7    Thailand

8.4.8    Vietnam

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Peru

8.5.5    Colombia

8.6    Middle East & Africa

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    UAE

8.6.4    Israel

Chapter 9   Company Profiles

9.1    Novartis

9.2    Mylan

9.3    Amneal Pharmaceuticals, Inc

9.4    Zydus Pharmaceuticals, Inc

9.5    UCB

9.6    Hisamitsu Pharmaceutical Co.,Inc

9.7    Corium, Inc.

9.8    Micropoint Technologies.

9.9    Sparsha Pharma International Pvt. Ltd.

Data Tables

TABLE 1.   Market revenue, by type, 2022

TABLE 2.   Market share, by application, 2022

TABLE 3.   Market share, by end-use, 2022

TABLE 4.   Market share, by region, 2022

TABLE 5.   Global transdermal drug delivery systems market, 2018-2022 (USD Million)

TABLE 6.   Global transdermal drug delivery systems market, 2023 – 2030 (USD Million)

TABLE 7.   Global transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 8.   Global transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 9.   Global transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 10.   Global transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 11.   Global transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 12.   Global transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 13.   Global transdermal drug delivery systems market estimates and forecast, 2018-2022 (USD Million)

TABLE 14.   Global transdermal drug delivery systems market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 15.   Industry impact forces

TABLE 16.   Transdermal patches market estimates and forecast, 2018-2022 (USD Million)

TABLE 17.   Transdermal patches market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 18.   Drug-in-adhesive patches market estimates and forecast, 2018-2022 (USD Million)

TABLE 19.   Drug-in-adhesive patches market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 20.   Matrix patches market estimates and forecast, 2018-2022 (USD Million)

TABLE 21.   Matrix patches market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 22.   Reservoir membrane patches market estimates and forecast, 2018-2022 (USD Million)

TABLE 23.   Reservoir membrane patches market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 24.   Microneedle patches market estimates and forecast, 2018-2022 (USD Million)

TABLE 25.   Microneedle patches market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 26.   Transdermal semisolids market estimates and forecast, 2018-2022 (USD Million)

TABLE 27.   Transdermal semisolids market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 28.   Gels market estimates and forecast, 2018-2022 (USD Million)

TABLE 29.   Gels market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 30.   Ointments market estimates and forecast, 2018-2022 (USD Million)

TABLE 31.   Ointments market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 32.   Sprays market estimates and forecast, 2018-2022 (USD Million)

TABLE 33.   Sprays market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 34.   Pain management market estimates and forecast, 2018-2022 (USD Million)

TABLE 35.   Pain management market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 36.   Hormonal applications market estimates and forecast, 2018-2022 (USD Million)

TABLE 37.   Hormonal applications market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 38.   Central nervous system disorders market estimates and forecast, 2018-2022 (USD Million)

TABLE 39.   Central nervous system disorders market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 40.   Cardiovascular diseases market estimates and forecast, 2018-2022 (USD Million)

TABLE 41.   Cardiovascular diseases market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 42.   Others market estimates and forecast, 2018-2022 (USD Million)

TABLE 43.   Others market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 44.   Hospitals market estimates and forecast, 2018-2022 (USD Million)

TABLE 45.   Hospitals market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 46.   Clinics market estimates and forecast, 2018-2022 (USD Million)

TABLE 47.   Clinics market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 48.   Home care settings market estimates and forecast, 2018-2022 (USD Million)

TABLE 49.   Home care settings market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 50.   Others market estimates and forecast, 2018-2022 (USD Million)

TABLE 51.   Others market estimates and forecast, 2023 – 2030 (USD Million)

TABLE 52.   North America transdermal drug delivery systems market, by country, 2018-2022 (USD Million)

TABLE 53.   North America transdermal drug delivery systems market, by country, 2023 – 2030 (USD Million)

TABLE 54.   North America transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 55.   North America transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 56.   North America transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 57.   North America transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 58.   North America transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 59.   North America transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 60.   North America transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 61.   North America transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 62.   North America transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 63.   North America transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 64.   U.S. transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 65.   U.S. transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 66.   U.S. transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 67.   U.S. transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 68.   U.S. transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 69.   U.S. transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 70.   U.S. transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 71.   U.S. transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 72.   U.S. transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 73.   U.S. transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 74.   Canada transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 75.   Canada transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 76.   Canada transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 77.   Canada transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 78.   Canada transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 79.   Canada transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 80.   Canada transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 81.   Canada transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 82.   Canada transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 83.   Canada transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 84.   Europe transdermal drug delivery systems market, by country, 2018-2022 (USD Million)

TABLE 85.   Europe transdermal drug delivery systems market, by country, 2023 – 2030 (USD Million)

TABLE 86.   Europe transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 87.   Europe transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 88.   Europe transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 89.   Europe transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 90.   Europe transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 91.   Europe transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 92.   Europe transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 93.   Europe transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 94.   Europe transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 95.   Europe transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 96.   Germany transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 97.   Germany transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 98.   Germany transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 99.   Germany transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 100.   Germany transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 101.   Germany transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 102.   Germany transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 103.   Germany transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 104.   Germany transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 105.   Germany transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 106.   UK transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 107.   UK transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 108.   UK transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 109.   UK transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 110.   UK transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 111.   UK transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 112.   UK transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 113.   UK transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 114.   UK transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 115.   UK transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 116.   France transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 117.   France transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 118.   France transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 119.   France transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 120.   France transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 121.   France transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 122.   France transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 123.   France transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 124.   France transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 125.   France transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 126.   Spain transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 127.   Spain transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 128.   Spain transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 129.   Spain transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 130.   Spain transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 131.   Spain transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 132.   Spain transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 133.   Spain transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 134.   Spain transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 135.   Spain transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 136.   Italy transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 137.   Italy transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 138.   Italy transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 139.   Italy transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 140.   Italy transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 141.   Italy transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 142.   Italy transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 143.   Italy transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 144.   Italy transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 145.   Italy transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 146.   Poland transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 147.   Poland transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 148.   Poland transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 149.   Poland transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 150.   Poland transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 151.   Poland transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 152.   Poland transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 153.   Poland transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 154.   Poland transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 155.   Poland transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 156.   Switzerland transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 157.   Switzerland transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 158.   Switzerland transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 159.   Switzerland transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 160.   Switzerland transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 161.   Switzerland transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 162.   Switzerland transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 163.   Switzerland transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 164.   Switzerland transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 165.   Switzerland transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 166.   Netherlands transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 167.   Netherlands transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 168.   Netherlands transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 169.   Netherlands transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 170.   Netherlands transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 171.   Netherlands transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 172.   Netherlands transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 173.   Netherlands transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 174.   Netherlands transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 175.   Netherlands transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 176.   Asia Pacific transdermal drug delivery systems market, by country, 2018-2022 (USD Million)

TABLE 177.   Asia Pacific transdermal drug delivery systems market, by country, 2023 – 2030 (USD Million)

TABLE 178.   Asia Pacific transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 179.   Asia Pacific transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 180.   Asia Pacific transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 181.   Asia Pacific transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 182.   Asia Pacific transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 183.   Asia Pacific transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 184.   Asia Pacific transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 185.   Asia Pacific transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 186.   Asia Pacific transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 187.   Asia Pacific transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 188.   China transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 189.   China transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 190.   China transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 191.   China transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 192.   China transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 193.   China transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 194.   China transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 195.   China transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 196.   China transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 197.   China transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 198.   Japan transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 199.   Japan transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 200.   Japan transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 201.   Japan transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 202.   Japan transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 203.   Japan transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 204.   Japan transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 205.   Japan transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 206.   Japan transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 207.   Japan transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 208.   India transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 209.   India transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 210.   India transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 211.   India transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 212.   India transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 213.   India transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 214.   India transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 215.   India transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 216.   India transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 217.   India transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 218.   Australia transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 219.   Australia transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 220.   Australia transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 221.   Australia transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 222.   Australia transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 223.   Australia transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 224.   Australia transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 225.   Australia transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 226.   Australia transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 227.   Australia transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 228.   South Korea transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 229.   South Korea transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 230.   South Korea transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 231.   South Korea transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 232.   South Korea transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 233.   South Korea transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 234.   South Korea transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 235.   South Korea transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 236.   South Korea transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 237.   South Korea transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 238.   Thailand transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 239.   Thailand transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 240.   Thailand transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 241.   Thailand transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 242.   Thailand transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 243.   Thailand transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 244.   Thailand transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 245.   Thailand transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 246.   Thailand transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 247.   Thailand transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 248.   Indonesia transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 249.   Indonesia transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 250.   Indonesia transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 251.   Indonesia transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 252.   Indonesia transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 253.   Indonesia transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 254.   Indonesia transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 255.   Indonesia transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 256.   Indonesia transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 257.   Indonesia transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 258.   Vietnam transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 259.   Vietnam transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 260.   Vietnam transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 261.   Vietnam transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 262.   Vietnam transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 263.   Vietnam transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 264.   Vietnam transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 265.   Vietnam transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 266.   Vietnam transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 267.   Vietnam transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 268.   MEA transdermal drug delivery systems market, by country, 2018-2022 (USD Million)

TABLE 269.   MEA transdermal drug delivery systems market, by country, 2023 – 2030 (USD Million)

TABLE 270.   MEA transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 271.   MEA transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 272.   MEA transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 273.   MEA transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 274.   MEA transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 275.   MEA transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 276.   MEA transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 277.   MEA transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 278.   MEA transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 279.   MEA transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 280.   South Africa transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 281.   South Africa transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 282.   South Africa transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 283.   South Africa transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 284.   South Africa transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 285.   South Africa transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 286.   South Africa transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 287.   South Africa transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 288.   South Africa transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 289.   South Africa transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 290.   Saudi Arabia transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 291.   Saudi Arabia transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 292.   Saudi Arabia transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 293.   Saudi Arabia transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 294.   Saudi Arabia transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 295.   Saudi Arabia transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 296.   Saudi Arabia transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 297.   Saudi Arabia transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 298.   Saudi Arabia transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 299.   Saudi Arabia transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 300.   UAE transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 301.   UAE transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 302.   UAE transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 303.   UAE transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 304.   UAE transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 305.   UAE transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 306.   UAE transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 307.   UAE transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 308.   UAE transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 309.   UAE transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)

TABLE 310.   Israel transdermal drug delivery systems market, by type, 2018-2022 (USD Million)

TABLE 311.   Israel transdermal drug delivery systems market, by type, 2023 – 2030 (USD Million)

TABLE 312.   Israel transdermal drug delivery systems market, by transdermal patches, 2018-2022 (USD Million)

TABLE 313.   Israel transdermal drug delivery systems market, by transdermal patches, 2023–2030 (USD Million)

TABLE 314.   Israel transdermal drug delivery systems market, by transdermal semisolids, 2018-2022 (USD Million)

TABLE 315.   Israel transdermal drug delivery systems market, by transdermal semisolids, 2023–2030 (USD Million)

TABLE 316.   Israel transdermal drug delivery systems market, by application, 2018-2022 (USD Million)

TABLE 317.   Israel transdermal drug delivery systems market, by application, 2023 – 2030 (USD Million)

TABLE 318.   Israel transdermal drug delivery systems market, by end-use, 2018-2022 (USD Million)

TABLE 319.   Israel transdermal drug delivery systems market, by end-use, 2023 – 2030 (USD Million)
 

Charts & Figures

FIG. 1   MRS report coverage: Critical research elements

FIG. 2   Industry segmentation

FIG. 3   Top-down approach

FIG. 4   Market estimation and forecast methodology

FIG. 5   Market forecasting methodology

FIG. 6   Breakdown of primary participants

FIG. 7   Global transdermal drug delivery systems industry 360⁰ synopsis, 2023 - 2030 (USD Mn)

FIG. 8   Growth potential analysis, by type

FIG. 9   Growth potential analysis, by application

FIG. 10   Growth potential analysis, by end-use

FIG. 11   Company matrix analysis

FIG. 12   Strategic dashboard

FIG. 13   Competitive analysis of major market players

FIG. 14   Competitive positioning matrix

FIG. 15   Strategic outlook matrix

Research Methodology